68124-22-1

Basic information

• Product Name: 1-O-benzyl-β-lacto-N-neotetraose
• Synonyms: 1-O-benzyl-β-lacto-N-neotetraose
• CAS NO: 68124-22-1
• Molecular Weight: 797.762
• Mol File: 68124-22-1.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 1-O-benzyl-β-lacto-N-neotetraose(CAS DataBase Reference)
• NIST Chemistry Reference: 1-O-benzyl-β-lacto-N-neotetraose(68124-22-1)
• EPA Substance Registry System: 1-O-benzyl-β-lacto-N-neotetraose(68124-22-1)

Safety Data

• Hazardous Substances Data: 68124-22-1(Hazardous Substances Data)

Upstream product

• 68124-21-0 C₃₁H₄₉NO₂₀ 
• 124-41-4 sodium methylate 
• 1429255-03-7 C₈₀H₈₃NO₃₂ 
• 1329426-63-2 C₃₃H₄₈Cl₃NO₂₁ 
• 108-24-7 acetic anhydride 
• 1445783-71-0 C₇₆H₆₀Cl₉NO₂₃ 
• 86520-63-0 2,3,4,6-tetra-O-acetyl-α-galactopyranosyl trichloroacetimidate 

Downstream Products

• 86594-19-6 lacto-N-neo-tetraose 

Relevant articles and documents

Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine

The present invention relates to a method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt, formula (I)) especially in large scale, as well as intermediates in the synthesis, a new crystal form (polymorph) of LNnt, and the use thereof in pharmaceutical or nutritional compositions.

A METHOD FOR OBTAINING CRYSTALLINE LACTO-N-TETRAOSE AND LACTO-N-NEOTETRAOSE PRECURSORS AND MIXTURES THEREOF

A mixture of, preferably a mixture consisting essentially of, an lacto-N-tetraose (LNT) precursor (1) and an lacto-N-neotetraose (LNnT) precursor (2), (formula 1, 2), where R is a group removable by hydrogenolysis and R3 is either a group remov

DERIVATIZATION OF OLIGOSACCHARIDES

The invention relates to a method for purifying, separating and/or isolating an oligosaccharide of general formula 1 or a salt thereof (general formula 1) wherein R1 is fucosyl or H, R2 is fucosyl or H, R3 is selected from H, sialyl, N-acetyl-lactosaminyl and lacto-N-biosyl groups, wherein the N-acetyl lactosaminyl group may carry a glycosyl residue comprising one or more N-acetyl-lactosaminyl and/or one or more lacto-N-biosyl groups; each of the N-acetyl-lactosaminyl and lacto-N-biosyl groups can be substituted with one or more sialyl and/or fucosyl residue, R4 is selected from H, or sialyl and N-acetyl-lactosaminyl groups optionally substituted with a glycosyl residue comprising one or more N-acetyl-lactosaminyl and/or one or more lacto-N-biosyl groups; each of the N-acetyl-lactosaminyl and lacto-N-biosyl groups can be substituted with one or more sialyl and/or fucosyl residue, wherein at least one of the R1, R2, R3 or R4 groups differs from H, comprising the steps: a) one or more compounds of general formula 1 is/are subjected to an anomeric O-alkylation reaction in the presence of R-X to yield a mixture comprising one or more compounds of general formula 2 or salts thereof (general formula 2) wherein X is a leaving group such as halogen, alkyl- or arylsulfonyloxy, R is a group removable by hydrogenolysis, and R1, R2, R3 and R4 are as defined above, and wherein at least one of the R1, R2, R3 or R4 groups differs from H, b) the mixture comprising one or more compounds of general formula 2 obtained in step a) is subjected to chromatography and/or crystallization to give one or more individual compounds of general formula 2 each in substantially pure form, c) an individual compound of general formula 2 in substantially pure form obtained in step b) is subjected to catalytic hydrogenolysis to yield a compound of general formula 1.